Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo aims to prevent pancreatitis in patients with Sky-High fat levels

NCT ID NCT07308392

Recruiting now Disease control Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 13, 2026 · Updated 25 times

Summary

This study tests two experimental drugs, HRS-7249 and SHR-1918, in people with very high triglycerides (a type of fat in the blood) who are at high risk for acute pancreatitis, a painful and dangerous inflammation of the pancreas. About 108 adults will receive either the drugs or a placebo to see if the combination safely lowers fat levels and reduces pancreatitis attacks. The goal is to control the condition and prevent emergencies, not to cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE HYPERTRIGLYCERIDEMIA WITH A HIGH RISK OF ACUTE PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

    RECRUITING

    Nanjing, Jiangsu, 210029, China

    Contact

Conditions

Explore the condition pages connected to this study.

SEVERE HYPERTRIGLYCERIDEMIA WITH A HIGH RISK OF ACUTE PANCREATITIS